Fallopian Tube Cancer Clinical Trials

27 studies are recruiting for fallopian tube cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Boston, Massachusetts 10 New York, New York 10 St Louis, Missouri 9 Fairfax, Virginia 8 Houston, Texas 8 Oklahoma City, Oklahoma 8 Philadelphia, Pennsylvania 8 Pittsburgh, Pennsylvania 8 Chicago, Illinois 7 Nashville, Tennessee 7 Portland, Oregon 7 Atlanta, Georgia 6 Columbus, Ohio 6 Detroit, Michigan 6 Austin, Texas 5 Birmingham, Alabama 5 Dallas, Texas 5 Los Angeles, California 5 Orlando, Florida 5 Providence, Rhode Island 5 San Francisco, California 5 Sarasota, Florida 5 Seattle, Washington 5 Eugene, Oregon 4 Fort Worth, Texas 4 Hackensack, New Jersey 4 Jacksonville, Florida 4 Minneapolis, Minnesota 4 New Haven, Connecticut 4 Norfolk, Virginia 4 Rochester, Minnesota 4 San Antonio, Texas 4 Santa Barbara, California 4 Sioux Falls, South Dakota 4 Spokane, Washington 4 Tampa, Florida 4 West Palm Beach, Florida 4 Albuquerque, New Mexico 3 Aurora, Colorado 3 Baltimore, Maryland 3 Chattanooga, Tennessee 3 Cincinnati, Ohio 3 Cleveland, Ohio 3 Duarte, California 3 Fort Myers, Florida 3 Indianapolis, Indiana 3 Miami Beach, Florida 3 Milwaukee, Wisconsin 3 New Brunswick, New Jersey 3 New Orleans, Louisiana 3 Orange, California 3 Phoenix, Arizona 3 Salt Lake City, Utah 3 San Diego, California 3 Tucson, Arizona 3

Studies, page 2

  1. A Beta-only IL-2 ImmunoTherapY Study

    This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Sharp Memorial Hospital, San Diego, California
    Locations
    27 in total
    Run by
    Medicenna Therapeutics, Inc.

    See if you can join NCT05086692 on ClinicalTrials.gov

  2. Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

    RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois
    Run by
    Northwestern University

    See if you can join NCT00005095 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.